Use of Biperiden for the Prevention of Post-traumatic Epilepsy

NCT01048138 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

123

Enrollment

OTHER

Sponsor class

Stopped Recruitment and funding issues, together with the event of the SARS-CoV-2 pandemic prompted an adjustment in the study design to stop enrollment at 123 patients.

Conditions

Traumatic Brain Injury

Interventions

DRUG: Biperiden Lactate
DRUG: Placebo

Sponsor

Federal University of São Paulo

Collaborators

[object Object]